Multiplex protein assays allow multiple targets quantification in a single sample, a bit like performing up to 40 different ELISAs in one go. Outsourcing Multiplex Protein Quantification projects to experts may work out more cost effective and time saving. It saves you the hassle of setting up a new technology in your lab, and you can rely on people with years of expertise in the technology to generate quality data on the very first run. Should you wish to set it up in your own lab, some technologies are easily adaptable if you have access to the equipment.
The global Protein Multiplex Assays market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029.
Key companies engaged in the Protein Multiplex Assays industry include Luminex Corporation, Thermo Fisher Scientific, Bio-Rad Laboratories, Qiagen, Abcam, Becton, Dickinson and Company, Merck KGaA and Agilent Technologies, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % value of Protein Multiplex Assays were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Protein Multiplex Assays market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Protein Multiplex Assays market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.
By Company
Luminex Corporation
Thermo Fisher Scientific
Bio-Rad Laboratories
Qiagen
Abcam
Becton
Dickinson and Company
Merck KGaA
Agilent Technologies
Bio-Techne
Shimadzu Biotech
Segment by Type
Planar Protein Assays
Bead-Based Protein Assays
Other Protein Assays
Segment by Application
Pharmaceutical & Biotechnology Companies
Hospitals & Research Institutes
Reference Laboratories
Other End Users
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Protein Multiplex Assays report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. 麻豆原创 Opportunities and Challenges
Chapter 3: Companies鈥� Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies鈥� Outline
Chapter 12: 麻豆原创 Conclusions
Chapter 13: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Protein Multiplex Assays 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Planar Protein Assays
1.2.3 Bead-Based Protein Assays
1.2.4 Other Protein Assays
1.3 麻豆原创 by Application
1.3.1 Global Protein Multiplex Assays 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Hospitals & Research Institutes
1.3.4 Reference Laboratories
1.3.5 Other End Users
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Protein Multiplex Assays 麻豆原创 Perspective (2018-2029)
2.2 Protein Multiplex Assays Growth Trends by Region
2.2.1 Global Protein Multiplex Assays 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Protein Multiplex Assays Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Protein Multiplex Assays Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Protein Multiplex Assays 麻豆原创 Dynamics
2.3.1 Protein Multiplex Assays Industry Trends
2.3.2 Protein Multiplex Assays 麻豆原创 Drivers
2.3.3 Protein Multiplex Assays 麻豆原创 Challenges
2.3.4 Protein Multiplex Assays 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Protein Multiplex Assays Players by Revenue
3.1.1 Global Top Protein Multiplex Assays Players by Revenue (2018-2023)
3.1.2 Global Protein Multiplex Assays Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Protein Multiplex Assays 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Protein Multiplex Assays Revenue
3.4 Global Protein Multiplex Assays 麻豆原创 Concentration Ratio
3.4.1 Global Protein Multiplex Assays 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Protein Multiplex Assays Revenue in 2022
3.5 Protein Multiplex Assays Key Players Head office and Area Served
3.6 Key Players Protein Multiplex Assays Product Solution and Service
3.7 Date of Enter into Protein Multiplex Assays 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Protein Multiplex Assays Breakdown Data by Type
4.1 Global Protein Multiplex Assays Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Protein Multiplex Assays Forecasted 麻豆原创 Size by Type (2024-2029)
5 Protein Multiplex Assays Breakdown Data by Application
5.1 Global Protein Multiplex Assays Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Protein Multiplex Assays Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Protein Multiplex Assays 麻豆原创 Size (2018-2029)
6.2 North America Protein Multiplex Assays 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Protein Multiplex Assays 麻豆原创 Size by Country (2018-2023)
6.4 North America Protein Multiplex Assays 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Protein Multiplex Assays 麻豆原创 Size (2018-2029)
7.2 Europe Protein Multiplex Assays 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Protein Multiplex Assays 麻豆原创 Size by Country (2018-2023)
7.4 Europe Protein Multiplex Assays 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Protein Multiplex Assays 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Protein Multiplex Assays 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Protein Multiplex Assays 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Protein Multiplex Assays 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Protein Multiplex Assays 麻豆原创 Size (2018-2029)
9.2 Latin America Protein Multiplex Assays 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Protein Multiplex Assays 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Protein Multiplex Assays 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Protein Multiplex Assays 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Protein Multiplex Assays 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Protein Multiplex Assays 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Protein Multiplex Assays 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Luminex Corporation
11.1.1 Luminex Corporation Company Detail
11.1.2 Luminex Corporation Business Overview
11.1.3 Luminex Corporation Protein Multiplex Assays Introduction
11.1.4 Luminex Corporation Revenue in Protein Multiplex Assays Business (2018-2023)
11.1.5 Luminex Corporation Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Protein Multiplex Assays Introduction
11.2.4 Thermo Fisher Scientific Revenue in Protein Multiplex Assays Business (2018-2023)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Detail
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Protein Multiplex Assays Introduction
11.3.4 Bio-Rad Laboratories Revenue in Protein Multiplex Assays Business (2018-2023)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 Qiagen
11.4.1 Qiagen Company Detail
11.4.2 Qiagen Business Overview
11.4.3 Qiagen Protein Multiplex Assays Introduction
11.4.4 Qiagen Revenue in Protein Multiplex Assays Business (2018-2023)
11.4.5 Qiagen Recent Development
11.5 Abcam
11.5.1 Abcam Company Detail
11.5.2 Abcam Business Overview
11.5.3 Abcam Protein Multiplex Assays Introduction
11.5.4 Abcam Revenue in Protein Multiplex Assays Business (2018-2023)
11.5.5 Abcam Recent Development
11.6 Becton
11.6.1 Becton Company Detail
11.6.2 Becton Business Overview
11.6.3 Becton Protein Multiplex Assays Introduction
11.6.4 Becton Revenue in Protein Multiplex Assays Business (2018-2023)
11.6.5 Becton Recent Development
11.7 Dickinson and Company
11.7.1 Dickinson and Company Company Detail
11.7.2 Dickinson and Company Business Overview
11.7.3 Dickinson and Company Protein Multiplex Assays Introduction
11.7.4 Dickinson and Company Revenue in Protein Multiplex Assays Business (2018-2023)
11.7.5 Dickinson and Company Recent Development
11.8 Merck KGaA
11.8.1 Merck KGaA Company Detail
11.8.2 Merck KGaA Business Overview
11.8.3 Merck KGaA Protein Multiplex Assays Introduction
11.8.4 Merck KGaA Revenue in Protein Multiplex Assays Business (2018-2023)
11.8.5 Merck KGaA Recent Development
11.9 Agilent Technologies
11.9.1 Agilent Technologies Company Detail
11.9.2 Agilent Technologies Business Overview
11.9.3 Agilent Technologies Protein Multiplex Assays Introduction
11.9.4 Agilent Technologies Revenue in Protein Multiplex Assays Business (2018-2023)
11.9.5 Agilent Technologies Recent Development
11.10 Bio-Techne
11.10.1 Bio-Techne Company Detail
11.10.2 Bio-Techne Business Overview
11.10.3 Bio-Techne Protein Multiplex Assays Introduction
11.10.4 Bio-Techne Revenue in Protein Multiplex Assays Business (2018-2023)
11.10.5 Bio-Techne Recent Development
11.11 Shimadzu Biotech
11.11.1 Shimadzu Biotech Company Detail
11.11.2 Shimadzu Biotech Business Overview
11.11.3 Shimadzu Biotech Protein Multiplex Assays Introduction
11.11.4 Shimadzu Biotech Revenue in Protein Multiplex Assays Business (2018-2023)
11.11.5 Shimadzu Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Luminex Corporation
Thermo Fisher Scientific
Bio-Rad Laboratories
Qiagen
Abcam
Becton
Dickinson and Company
Merck KGaA
Agilent Technologies
Bio-Techne
Shimadzu Biotech
听
听
*If Applicable.
